Document is current
Any future updates will be listed below
-
Authors
Elijošius, Rokas https://orcid.org/0000-0001-6397-0002
King-Smith, Emma https://orcid.org/0000-0002-2999-0955
Faber, Felix A.
Bernier, Louise
Berritt, Simon https://orcid.org/0000-0001-5572-6771
Farrell, William P. https://orcid.org/0000-0002-3341-9831
Hou, Xinjun https://orcid.org/0000-0002-3473-8455
Klug-McLeod, Jacquelyn L.
Mustakis, Jason https://orcid.org/0000-0002-8683-0691
Sach, Neal W. https://orcid.org/0000-0002-9966-7459
Yang, Qingyi https://orcid.org/0000-0001-5269-0494
Howard, Roger M. https://orcid.org/0000-0001-5884-4896
Lee, Alpha A. https://orcid.org/0000-0002-9616-3108
-
Funding
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (EP/X034712/1)
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 31 July 2025
First Online: 26 August 2025
Competing interests
: A.A.L. is a co-founder and owns equity in PostEra Inc. and Byterat Ltd. L.B., S.B., X.H., J.L.K.M., J.M., N.W.S., Q.Y., and R.M.H. are employed by Pfizer Inc. WPF is employed by Virscidian Inc. and formerly at Pfizer. F.A.F. is employed by AstraZeneca at the time of publication; however, none of the work presented in this manuscript was conducted at or influenced by this affiliation. The remaining authors declare no competing interests.
